Searched for: in-biosketch:true
person:gudesm01
Variability of objective gait measures across the expanded disability status scale in people living with multiple sclerosis: A cross-sectional retrospective analysis
Zanotto, Tobia; Sosnoff, Jacob J; Ofori, Edward; Golan, Daniel; Zarif, Myassar; Bumstead, Barbara; Buhse, Marijean; Kaczmarek, Olivia; Wilken, Jeffrey; Muratori, Lisa; Covey, Thomas J; Gudesblatt, Mark
BACKGROUND:The Expanded Disability Status Scale (EDSS) is widely utilized in clinical trials and routine care to evaluate disease burden and progression among people with multiple sclerosis (pwMS). However, instrumental gait measures may be more suitable than EDSS to track walking disability in pwMS. In this cross-sectional study, we aimed to quantify the variability of spatiotemporal gait measures within homologous EDSS categories. METHODS:A total of 205 pwMS (age=46.5[SD=10.5] years, 72.2% female, EDSS range=1.0-6.5) were studied in this retrospective analysis. Participants underwent walking assessments through the GAITRite system and the following spatiotemporal gait measures were recorded: gait speed, mean normalized velocity (MNV), base of support, stride length, step length, percentage of gait cycle spent in double support and single support, and functional ambulation profile. The EDSS was evaluated by a certified neurologist. RESULTS:≤0.17). Overall, the percent variability of gait measures increased across EDSS categories, with coefficients of variation ranging from 6.9% to 37.2% in the minimal disability group (EDSS≤2.5), 8.1% to 33.4% and 22.3% to 53.8% in the moderate (2.5<EDSS≤4.5) and severe (EDSS>4.5) disability groups, respectively. CONCLUSION/CONCLUSIONS:Spatiotemporal gait measures have great variability within homologous EDSS categories. The high percent variability of gait speed and MNV (up to more than 50%) suggests that walking ability varies substantially within and across disability levels. Therefore, in addition to the EDSS, more comprehensive (multidimensional), objective patient-centric metrics would be needed to accurately evaluate disability in pwMS.
PMID: 35124304
ISSN: 2211-0356
CID: 5342312
Measuring cognitive function by the SDMT across functional domains: Useful but not sufficient
Leach, Justin M; Cutter, Gary; Golan, Daniel; Doniger, Glen; Zarif, Myassar; Bumstead, Barbara; Buhse, Marijean; Kaczmarek, Olivia; Sethi, Avtej; Covey, Thomas; Penner, Iris-Katharina; Wilken, Jeffrey; Gudesblatt, Mark
BACKGROUND:The Symbol Digit Modalities Test (SDMT) is a common screen of cognitive function for people with Multiple Sclerosis (pwMS) but growing acknowledgement that people with cognitive impairment are a heterogeneous population suggests that a single screen may provide limited information. OBJECTIVE:To assess the adequacy of the SDMT in capturing impairment across specific cognitive domains as measured by a multi-domain cognitive assessment battery (CAB, NeuroTrax). METHODS:113 pwMS were assessed with SDMT and the CAB. Cognitive impairment in each CAB domain was defined as ≥1.5 SD below the normalized mean. Logistic regression models were fit for each CAB domain with domain-specific cognitive impairment as the outcome and SDMT as the predictor, and a classifier created by selecting cutpoints using the Youden Index. Model performance was assessed by predicting domain-specific cognitive impairment in an independent data set consisting of 81 pwMS. RESULTS:SDMT was a significant predictor of cognitive impairment in all outcomes considered (Odds Ratio: 0.885-0.950), but prediction metrics such as area under the receiver operating curve (AUC) were modest (0.623-0.778), and the alignment between observed/predicted impairment was less than optimal. CONCLUSION/CONCLUSIONS:The SDMT is not sufficient to differentiate between impaired and non-impaired pwMS across several cognitive domains.
PMID: 35259683
ISSN: 2211-0356
CID: 5342342
Cognitive Function in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate: 3-Year Longitudinal Analysis [Meeting Abstract]
Kaczmarek, O.; Sethi, A.; Bumstead, B.; Buhse, M.; Zarif, M.; Scott, N.; Mendoza, J. P.; Gudesblatt, M.
ISI:000796572500338
ISSN: 1352-4585
CID: 5342982
Multiple Sclerosis, Ocrelizumab and Cognition: 2-year Multi-Domain Cognitive Stability [Meeting Abstract]
Kaczmarek, O.; Sethi, A.; Bumstead, B.; Buhse, M.; Zarif, M.; Gudesblatt, M.
ISI:000796572500115
ISSN: 1352-4585
CID: 5342962
Disease Modifying Therapy Choice in People with Multiple Sclerosis in The Era of Covid: Characterizing Outcomes in Patients who Switched from anti-CD20 Therapies to Diroximel Fumarate [Meeting Abstract]
Kaczmarek, O.; Sethi, A.; Teng, E.; Bumstead, B.; Buhse, M.; Zarif, M.; Scott, N.; Gocke, A.; Mendoza, J. P.; Gudesblatt, M.
ISI:000796572500159
ISSN: 1352-4585
CID: 5342972
Multiple Sclerosis, Cognitive Function and Shared Decision Making Preference: A Process With a Problem [Meeting Abstract]
Kaczmarek, O.; Sethi, A.; Teng, E.; Bumstead, B.; Buhse, M.; Zarif, M.; Gudesblatt, M.
ISI:000796572500414
ISSN: 1352-4585
CID: 5342992
Multiple sclerosis and the presence of unrecognized immune deficiencies: a cross sectional analysis [Meeting Abstract]
Kaczmarek, O.; Sethi, A.; Teng, E.; Kodym, C.; Bumstead, B.; Buhse, M.; Zarif, M.; Gudesblatt, M.
ISI:000706771301195
ISSN: 1352-4585
CID: 5342922
Multiple Sclerosis and the Ability to Participate in Social Roles and Activities: Disease Impact Beyond Physical Disability [Meeting Abstract]
Kaczmarek, O.; Petroski, J.; Zodiatis, E.; Bumstead, B.; Buhse, M.; Zarif, M.; Golan, D.; Wilken, J.; Gudesblatt, M.
ISI:000669008200236
ISSN: 1352-4585
CID: 5342842
Multiple sclerosis, medication management, health literacy and accumulative cognitive impairment: is perception sufficient for performance? [Meeting Abstract]
Sethi, A.; Kaczmarek, O.; Petroski, J.; Bumstead, B.; Buhse, M.; Zarif, M.; Wilken, J.; Golan, D.; Krieger, S.; Doniger, G.; Gudesblatt, M.
ISI:000706771301102
ISSN: 1352-4585
CID: 5342912
Efficacy and Safety Outcomes After Transition From Glatiramer Acetate to Diroximel Fumarate: Results From the Phase 3 EVOLVE-MS-1 Study [Meeting Abstract]
Wray, S.; Wundes, A.; Arnold, D. L.; Singer, B. A.; Bowen, J. D.; Hunter, S. F.; Gudesblatt, M.; Chen, H.; Lyons, J.; Melikov, M.; Mendoza, J. P.; Messer, J.; Naismith, R. T.
ISI:000669008200077
ISSN: 1352-4585
CID: 5342832